Allogeneic transplantation of isolated islet cells in clinical practice

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 5, 2009, Pages 326-332

  Berman, Andrzej ^a   Pawelec, Krystian ^a   Fiedor, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Allogeneic transplantation; Diabetes mellitus; Islet cells

Indexed keywords

DACLIZUMAB; EFALIZUMAB; GLUCOSE; INSULIN DERIVATIVE; RAPAMYCIN; TACROLIMUS;

ALLOTRANSPLANTATION; BLOOD SAMPLING; CELL ENCAPSULATION; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; ENGRAFTMENT; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ISOLATED PANCREAS ISLET; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; NONHUMAN; PANCREAS; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; REVIEW; SPLEEN; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 67649400915     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.686     Document Type: Review

References (50)

1. Tatoń J. [Intensive treatment of type 1 diabetes mellitus]. Warszawa, Wydawnictwo Lekarskie, PZWL, 2004: 26-54,136-149.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progressive of long-term complications in insulin-dependent diabetes mellitus. N Engl JMed. 1993:75:894-903.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 1995; 113: 36-51.
4. Dufrane D, Gianello P. Pig Islet Xenotransplantation Into Non-human Primate Model. Transplantation. 2008; 86: 753-760.
5. Korsgren 0, Nilsson B, Berne C, et al. Current status of clinical islet transplantation. Transplantation. 2005; 79:1289-1293.
6. Fiorina P, Shapiro AM, Ricordi C, Secchi A. The Clinical Impact of Islet Transplantation. Am J Transplant. 2008; 8:1990-1997.
7. Ricordi C, Inverardi L, Kenyon NS, et al. Requirements for success in clinical islet transplantation. Transplantation. 2005; 79:1298-1300.
8. Kandaswamy R, Sutherland DE, Hering BJ. Improvement in islet yield from obese donors for human islet transplants. Transplantation. 2004; 78: 880-885.
9. O'Gorman D, Kin T, Murdoch T, et al. The standardization of pancreatic donors for islet isolation. Transplant Proc. 2005; 37:1309-1310.
10. Brandhorst H, Brandhorst 0, Hering BJ, et al. Body mass index of pancreatic donors: a decisive factor for human islet isolation. Exp Clin Endocnnol Diabetes. 1995; 103 (Suppl 2): 23-26.
11. Lakey JR, Kneteman NM, Rajotte RV, et al. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation. 2002; 73:1106-1110.
12. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988; 45: 673-676.
13. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343: 230-238.
14. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006; 355: 1318-1330.
15. Morita A, Kuroda Y, Fujino Y et al. Assessment of pancreas graft viability preserved by a two-layer {University of Wisconsin solution/perfluoro- chemical) method after significant warm ischemia. Transplantation. 1993; 55: 667-669.
16. Carlsson P0, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes. 2001; 50: 489-495.
17. Yin D, Ding JW, Shen J. Liver ischemia contributes to early islet fail ure following intraportal transplantation: benefits of liver ischemic-precon-ditioning. Am J Transplant. 2006; 6: 60-68.
18. Andersson A, Eriksson U, Petersson B. Failure of successful intras-plenic transplantation of islets from lean mice to cure obese-hyperglycae-mic mice, despite islet growth. Diabetologia. 1981; 20: 237-241.
19. Juang JH, Kuo CH, Hsu BR. Effects of multiple site implantation on islet transplantation. Transplantation Proc. 2002; 34: 2698-2699.
20. Juang JH, Hsu BR, Kuo CH. Islet transplantation at subcutaneous and intramuscular sites. Transplantation Proc. 2005; 37: 3479-3481.
21. Emamaullee JA, Davis J, Pawlick R, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008; 57: 1556-1566.
22. Emamaullee JA, Stanton L, Schur C, Shapiro AM. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes. 2007; 56:1289-1298.
23. Alejandro R, Cutfield RG, Shienvold FL, et al. Natural history of intrahe- patic canine islet cell autografts. J Clin Invest. 1986; 78:1339-1348.
24. Merani S, Toso C, Emamaullee J, Shapiro J. Optimal implantation site for pancreatic islet transplantation. Br J Surg. 2008; 95:1449-1461.
25. Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000; 105:125-133.
26. van Suylichem PT, Strubbe JH, Houwing H, et al. Rat islet isograft function. Effect of graft volume and transplantation site. Transplantation. 1994:57:1010-1017.
27. Kaufman DB, Morel P, Field MJ, et al. Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site. Transplantation. 1990; 50:385-391.
28. Stagner Jl, Rilo HL,White KK. The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. JOP. 2007; 8: 628-636.
29. Tchervenivanov N, Yuan S, Lipsett M, et al. Morphological and functional studies on submucosal islet transplants in normal and diabetic hamsters. Cell Transplant. 2002; 11: 529-537.
30. Sageshima J, Kirchhof N, Shibata S, et al. Small bowel subserosal space as a site for islet transplantation and local drug delivery. Transplant Proc. 2001; 33:1710.
31. Caiazzo R, Gmyr V, Hubert T, et al. Evaluation of alternative sites for islet transplantation in the minipig: interest and limits of the gastric submucosa. Transplant Proc. 2007; 39: 2620-2623.
32. Posselt AM, Barker CF, Tomaszewski JE, et al. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science. 1990; 249:1293-1295.
33. Watt PC, Mullen Y, Nomura Y, et al. Successful engraftment of autologous and allogeneic islets into the porcine thymus. J Surg Res. 1994; 56:367-371.
34. Rayat GR, Korbutt GS, Elliott JF, Rajotte RV. Survival and function of syngeneic rat islet grafts placed within the thymus versus under the kidney capsule. Cell Transplant. 1997; 6: 597-602.
35. Ar'Rajab A, Dawidson IJ, Harris RB, Sentementes JT. Immune privilege of the testis for islet xenotransplantation (rat to mouse). Cell Transplant. 1994; 3: 493-498.
36. Selawry HP, Cameron DF. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 1993; 2:123-129.
37. Tze WJ, Tai J. Intracerebral allotransplantation of purified pancreatic endocrine cells and pancreatic islets in diabetic rats. Transplantation. 1984; 38:107-111.
38. Berney T, Pileggi A, Molano RD, et al. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation. 2003; 76:1669-1674.
39. Fiorina P, Folli F, Zerbini G, et al. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol. 2003; 14: 2150-2158.
40. Senior PA, Zeman M, Paty BW, et al. Changes in renal function after clinical islet transplantation: Four-year observational study. Am J Transplant. 2007; 7: 91-98.
41. Fiorina P, Gremizzi C, Maffi P, et al. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care. 2005; 28:1358-1365.
42. Venturini M, Fiorina P, Maffi P, et al. Early increase of retinal arterialand venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone. Transplantation. 2006; 81:1274-1277.
43. Lee TC, Barshes NR, 0'Mahony CA, et al. The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc. 2005; 37: 2263-2265.
44. Del Carro U, Fiorina P, Amadio S, et al. Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: Neurophysiological and skin biopsy longitudinal analysis. Diabetes Care. 2007; 30: 3063-3069.
45. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg. 2001; 233: 463-501.
46. Cantarovich D, Blancho G, Potiron N, et al. Rapid failure of pig islet transplantation in non human primates. Xenotransplantation. 2002; 9: 3.
47. Rood PP, Bottino R, Balamurugan AN, at al. Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation. 2007; 83: 202.
48. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2001; 142: 2115.
49. Sun Y, Ma X, Zhou D, et al. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenograft of microencapsulated porcine islets without immunisupression. J Clin Invest. 1996; 98:1417.
50. Abstracts of the Joint Meeting of the International Xenotransplantation Association |IXA), the International Pancreas and Islet Transplant Association (IPITA), and the Cell Transplant Society (CTS), Minneapolis, Minnesota, USA, September 15-20, 2007. Xenotransplantation. 2007; 14: 375.